home / stock / bolt / bolt short
Short Information | Bolt Biotherapeutics Inc. (NASDAQ:BOLT)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 308,121 |
Total Actual Volume | 2,083,958 |
Short Trends | |
---|---|
Cover Days | 17 |
Short Days | 0 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 15,406 |
Average Short Percentage | 15.59% |
Is there a BOLT Short Squeeze or Breakout about to happen?
See the BOLT Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-29-2024 | $1.14 | $1.12 | $1.14 | $1.09 | 25,497 | 2,854 | 11.19% |
04-26-2024 | $1.2 | $1.11 | $1.2 | $1.1 | 122,489 | 2,285 | 1.87% |
04-25-2024 | $1.2 | $1.16 | $1.21 | $1.15 | 13,475 | 66 | 0.49% |
04-24-2024 | $1.1 | $1.2002 | $1.21 | $1.09 | 154,904 | 32,924 | 21.25% |
04-23-2024 | $1.09 | $1.11 | $1.12 | $1.09 | 50,503 | 2,244 | 4.44% |
04-22-2024 | $1.11 | $1.11 | $1.13 | $1.09 | 39,426 | 4,782 | 12.13% |
04-19-2024 | $1.15 | $1.11 | $1.16 | $1.11 | 55,054 | 2,981 | 5.41% |
04-18-2024 | $1.14 | $1.14 | $1.16 | $1.11 | 90,067 | 6,762 | 7.51% |
04-17-2024 | $1.14 | $1.11 | $1.15 | $1.11 | 74,531 | 6,340 | 8.51% |
04-16-2024 | $1.15 | $1.15 | $1.15 | $1.08 | 101,723 | 35,925 | 35.32% |
04-15-2024 | $1.19 | $1.13 | $1.2 | $1.12 | 174,826 | 19,809 | 11.33% |
04-12-2024 | $1.25 | $1.2 | $1.28 | $1.17 | 338,930 | 34,934 | 10.31% |
04-11-2024 | $1.24 | $1.27 | $1.2799 | $1.24 | 52,957 | 18,590 | 35.1% |
04-10-2024 | $1.28 | $1.25 | $1.288 | $1.24 | 71,364 | 14,349 | 20.11% |
04-09-2024 | $1.36 | $1.285 | $1.36 | $1.22 | 152,547 | 22,403 | 14.69% |
04-08-2024 | $1.35 | $1.37 | $1.3999 | $1.32 | 54,158 | 16,471 | 30.41% |
04-05-2024 | $1.37 | $1.33 | $1.37 | $1.32 | 28,752 | 11,829 | 41.14% |
04-04-2024 | $1.35 | $1.33 | $1.36 | $1.32 | 42,197 | 4,051 | 9.6% |
04-03-2024 | $1.37 | $1.35 | $1.48 | $1.3 | 203,324 | 29,480 | 14.5% |
04-02-2024 | $1.44 | $1.4 | $1.4799 | $1.36 | 237,234 | 39,042 | 16.46% |
News, Short Squeeze, Breakout and More Instantly...
Bolt Biotherapeutics Inc. Company Name:
BOLT Stock Symbol:
NASDAQ Market:
– BDC-1001 (trastuzumab imbotolimod) Phase 2 studies in four HER2-positive tumor types advancing toward 2024 milestones – BDC-3042 Phase 1 study successfully cleared safety assessments in the first three dose level cohorts – Cash balanc...
REDWOOD CITY, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will present a company overview at the TD Cowen 44 th Annual He...
-- Transformational Leader Brings Three Decades of Global Experience in Pharmaceutical and Biotechnology Product Development and Commercialization...